Brief: Ryvu Therapeutics Q2 Net Loss At 33.7 Million Zlotys
18/09/2025 16:16
Sept 18 (Reuters) - Ryvu Therapeutics SA RVU.WA: Q2 NET LOSS AT 33.7 MILLION ZLOTYS Q2 OPERATING REVENUE 21.4 MILLION ZLOTYS Q2 OPERATING LOSS 27.7 MILLION ZLOTYS Source text: ID:nEMyr07Sa Further company coverage: RVU.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project